NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA

LUND, Sweden, May 10, 2019 -- (Healthcare Sales & Marketing Network) -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the US Food and Drug Administration, FDA, has approved NeuroVive's IND (Investigational New Dru... Biopharmaceuticals, Neurology, FDA NeuroVive Pharmaceutical, NeuroSTAT, traumatic brain injury
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news